SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

NCT00335166 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Stage Parkinson Disease

Interventions

DRUG: Pardaprunox
DRUG: pramipexole
DRUG: Placebo Comparator

Sponsor

Solvay Pharmaceuticals